This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Universitá Degli Studi Di Siena. Active years: 2009-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2013
Title: Francesco Bondavalli: Innovator in Pharmaceutical Chemistry
Introduction
Francesco Bondavalli is a notable inventor based in Siena, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical applications. With a total of 2 patents, his work focuses on innovative solutions for treating bone-related diseases and tumors.
Latest Patents
Francesco's latest patents include the invention of 4-substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine. This invention relates to a compound that has the potential to be used in the treatment of various bone-related diseases and tumors. Another significant patent involves substituted pyrazolo[3,4-D]pyrimidines as anti-tumor agents, providing a compound that can be utilized in cancer treatment.
Career Highlights
Francesco Bondavalli is affiliated with the Università Degli Studi Di Siena, where he continues to engage in research and development. His academic background and ongoing research contribute to advancements in pharmaceutical sciences.
Collaborations
Francesco has collaborated with notable colleagues such as Maurizio Botta and Olga Bruno. These partnerships enhance the scope and impact of his research efforts.
Conclusion
Francesco Bondavalli is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for innovative treatments. His contributions are vital in addressing significant health challenges, particularly in oncology and bone health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile